3D Printed Custom Applicators for HDR BT (DISCO)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorRoyal North Shore Hospital
About this trial
Intracavitary brachytherapy for gynaecological cancer currently use cylinder-type applicators or custom wax moulds to place a radioactive source in close proximity to the treatment area and provide highly conformal dose distributions. This study is a Phase IIa non-randomised interventional pilot trial that will investigate the feasibility of successfully treating patients with 3D-printed custom applicators.
Eligibility criteria
Qualifiers
Able to give informed consent
Patients indicated for intracavitary brachytherapy
FIGO stage I-IVA
ECOG 0-2
Disqualifiers
Pregnancy
Patients contraindicated for brachytherapy
Inflammatory bowel disease/history of adhesions/bowel obstruction
Renal transplant/horseshoe kidney
Trial design
Treatments tested in this trial
- 3D-printed custom applicator
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Royal North Shore Hospital
Lead sponsor
Northern Sydney and Central Coast Area Health Service
Collaborator
Source ClinicalTrials.gov